title: Re: Baker DL et al. Evaluation of two commercial omalizumab/free IgE immunoassays: implications of use during therapy. Curr Med Res Opin 2014;30:913-22.
authors.affiliation: Wollankstr. 133, 13187 Berlin , Germany.
authors.forename: Pavel
authors.initials: P
authors.lastname: Strohner
authors.forename: Gunther
authors.initials: G
authors.lastname: Becher
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D001249:Asthma / Q000097:blood* / Q000188:drug therapy*; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D007073:Immunoglobulin E / Q000097:blood*
chemical_list: D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D007073:Immunoglobulin E